These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 582449)
41. [Hyperthyroidism treated with I-131 with dosimetry. Critical study and results]. Savoie JC; Massin JP Ann Endocrinol (Paris); 1974; 35(1):36-7. PubMed ID: 4479472 [No Abstract] [Full Text] [Related]
42. A thermoluminescent method for estimation of effective thyroidal half-life of therapeutic 131I in toxic goitre. Malone JF; Cullen MJ Br J Radiol; 1975 Sep; 48(573):762-4. PubMed ID: 1182436 [TBL] [Abstract][Full Text] [Related]
43. [Therapy with 131I to hyperthyroidism Graves disease resolution: dose selection]. Lopes MH Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1031-3. PubMed ID: 18157375 [No Abstract] [Full Text] [Related]
44. [Proceedings: Results of reduction of the initial dosage of 131 I in the treatment of Basedow's disease]. Mori T; Konishi J; Ikekubo K; Morita R; Sakurami T Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):423. PubMed ID: 4480298 [No Abstract] [Full Text] [Related]
45. Measurement of the Dose to the Family Members Taking Care of Thyroid Cancer Patients Undergoing I-131 Therapy in Nuclear Medicine Using TLD-100. Zehtabian M; Dehghan N; Danaei Ghazanfarkhani M; Haghighatafshar M; Sina S Radiat Prot Dosimetry; 2017 May; 174(4):541-544. PubMed ID: 27555655 [TBL] [Abstract][Full Text] [Related]
46. Estimated Dose to Family Members of Patients Treated with Radioiodine. Kochovska MZ; Jokic VS; Majstorov V; Dugonjic S Radiat Prot Dosimetry; 2017 Apr; 174(2):250-254. PubMed ID: 27247441 [TBL] [Abstract][Full Text] [Related]
47. [Determination of the irradiation dose received by the ovaries during a treatment or test with radioactive iodine]. BERCY A J Belge Radiol; 1957; 40(3):333-45. PubMed ID: 13475288 [No Abstract] [Full Text] [Related]
48. Administration of 131I capsule via nasogastric tube in an uncooperative patient with Graves disease. Lowry PA; Semenkovich JW; Scott LD; Zeck OF; Desai A; Lavis VR AJR Am J Roentgenol; 1990 Sep; 155(3):611-2. PubMed ID: 2117363 [No Abstract] [Full Text] [Related]
49. 125I therapy. Abbott EC; Martin R Ann Intern Med; 1977 Dec; 87(6):797. PubMed ID: 579292 [No Abstract] [Full Text] [Related]
50. Comment on a review of the physiological parameters in the dosimetry of 123I- and 131I-labelled hippuran. Balsenc L; Beeler R; Vernet D Int J Appl Radiat Isot; 1979 Dec; 30(12):789. PubMed ID: 528064 [No Abstract] [Full Text] [Related]
51. [Effect of I 131 on the testicles and ovaries of mice; histomorphological study]. AVANZINI S G Med Mil; 1956; 106(2):243. PubMed ID: 13345024 [No Abstract] [Full Text] [Related]
52. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I. Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745 [TBL] [Abstract][Full Text] [Related]
53. Absorbed dose to ovaries and uterus during 131I-treatment of hyperthyroidism: comparison between in vivo TLD measurements and calculations. Philippon B; Briere J Health Phys; 1979 Jun; 36(6):727-9. PubMed ID: 582449 [No Abstract] [Full Text] [Related]
54. Absorbed dose to ovaries or uterus during a 131I-therapeutic of cancer or hyperthyroidism: comparison between in vivo measurements by TLD and calculations. Briere J; Philippon B Int J Appl Radiat Isot; 1979 Oct; 30(10):643-6. PubMed ID: 583466 [No Abstract] [Full Text] [Related]
55. Iodine-131 treatment of Graves' disease using modified early iodine-131 uptake measurements in therapy dose calculations. Hayes AA; Akre CM; Gorman CA J Nucl Med; 1990 Apr; 31(4):519-22. PubMed ID: 2324829 [TBL] [Abstract][Full Text] [Related]
56. Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism. Robertson JS; Gorman CA J Nucl Med; 1976 Sep; 17(9):826-35. PubMed ID: 956897 [TBL] [Abstract][Full Text] [Related]